📣 C4IP today announced that Coke Morgan Stewart, a nationally recognized leader in IP law and policy and former @USPTO deputy director, has joined the organization as president and CEO.
Her appointment marks a new chapter for C4IP as it expands its reach and advocacy for strong and secure IP rights.
Read our full statement:
c4ip.org/council-for-innovat…
The United States' multibillion-dollar intellectual property trade surplus underscores its immense value as a strategic asset.
David Kappos, C4IP co-chair and former USPTO director, explains how strong IP protections promote American innovation and drive our country's economic growth.
Supporters of the ETHIC Act frame it as a way to reduce drug prices by preventing pharmaceutical companies from constructing so-called "patent thickets."
But those supporters are misunderstanding, or misconstruing, how the patent system works.
Get the facts on the ETHIC Act:
c4ip.org/wp-content/uploads/…
"Chinese courts have recently asserted the authority to set worldwide licensing terms for SEPs, threatening market-based licensing and the value of American inventions."
Read more on this and other IP concerns in our public comment to @USTradeRep:
c4ip.org/wp-content/uploads/…
Innovation is America's backbone. Are your representatives doing their part to protect it?
Ahead of the midterms, see how their records measure up on our Congressional Innovation Scorecard ⬇️
c4ip.org/interactive-scoreca…
Far from being a tactic to extend market exclusivity through duplicative patents, terminal disclaimers prevent duplicative patenting.
Yet some critics repeatedly argue that drug patents linked by terminal disclaimers are duplicative and unnecessary.
Our blog post sets the record straight:
c4ip.org/fact-check-correcti…
Charles Hull transformed manufacturing, medicine, and design through his invention of stereolithography -- better known as 3D printing.
During IP Month, we're recognizing innovators like Hull and the IP rights that help turn groundbreaking ideas into real-world technologies.
Learn more about Hull's story:
c4ip.org/inventor-spotlight-…
"As artificial intelligence continues to transform how content is created and distributed, policymakers must ensure that individuals are not left vulnerable to exploitation and deception."
- C4IP Executive Director Frank Cullen
See how the NO FAKES Act would help:
c4ip.org/council-for-innovat…
ICYMI: The United States is among the top three most innovative countries, according to @WIPO's 2026 Global Innovation Index.
Dig into the data:
wipo.int/en/web/global-innov…
Check out C4IP Chief Policy Officer Jamie Simpson's new piece in @IPWatchdog on why Congress should reject the Medication Affordability and Patent Integrity Act:
"Inventions that often take more than a decade and enormous investment to reach patients are too valuable to be forfeited over a paperwork error."
Continue reading ⬇️
ipwatchdog.com/2026/10/21/do…
"...the incentives created by the IP system are foundational to the U.S. economy and, frankly, to economic freedom for individuals in the U.S."
- C4IP President and CEO Coke Morgan Stewart, speaking at @AUTM on the Road in Washington, D.C.
For more info about the event ⬇️
autm.net/events/autm-on-the-…
Intellectual Property Month offers an opportunity to celebrate the inventions that have shaped American life and the IP rights that enabled their success.
Our latest blog post highlights four patents that made history, from the nation's first patent to the sports bra.
Read it:
c4ip.org/celebrating-ip-mont…
A recent @IPWatchdog article highlights C4IP's support for the USPTO's proposed PTAB reforms and the PREVAIL Act.
It also notes C4IP's recommendation that any reforms preserve a viable process for challenging patents at the PTAB.
Take a look:
ipwatchdog.com/2026/10/15/in…
On the UK's proposed standard-essential patent reforms, MLex reports:
“The Council for Innovation Promotion (C4IP), meanwhile, voiced concern that the proposal could undermine negotiations that are better held privately.”
Continue reading:
mlex.com/mlex/articles/25389…
"The erosion of IP rights has made it much harder for U.S. startups, which rely heavily on venture capital funding, to secure the investment they need to enhance our country's defense capabilities."
- Former National Cyber Director Chris Inglis and C4IP Co-Chair and former USPTO Director Andrei Iancu
Read their full op-ed in @FortuneMagazine:
fortune.com/2026/10/20/forme…
C4IP President and CEO and former USPTO Deputy Director Coke Morgan Stewart recently joined the @AcadofInventors' Fellows Selection Committee, where she will help select fellows for the Class of 2026.
Learn more about the fellows program here:
academyofinventors.org/about…
📰 As Congress considers the Prohibiting Adversarial Patents Act, an MLex article highlights our concerns about restricting U.S. patent rights for certain Chinese companies, including questions about the bill's compatibility with international agreements and the risk of retaliation.
Take a look:
mlex.com/mlex/articles/25386…
Tomorrow, at the LES USA & Canada Annual Meeting in San Diego, CA, C4IP President and CEO and former USPTO Deputy Director Coke Morgan Stewart will take the stage for a fireside chat.
Check out the full agenda:
les2026.org/program/
Have a research idea that could inform intellectual property policy?
We offer grants of up to $25,000 to support original, empirically grounded research.
Learn more about our grant program ⬇️
c4ip.org/grant-program/
"At a time when China is making a concerted national effort to cultivate and support its next generation of technology companies, it is more important than ever that the United States strengthen its own startup innovation and IP ecosystem."
For more on IP, innovation, and competitiveness:
c4ip.org/wp-content/uploads/…
AI is changing how we invent. What does that mean for patents, trademarks, copyright, and trade secrets?
On November 9–10, @WIPO's Global Forum on IP and AI will bring experts together to examine this question.
Learn more about the hybrid event:
wipo.int/en/web/global-forum…

